checkpoint inhibitor-related Pneumonitis
Conditions
Interventions
Case series:NA
Sponsors
Nanfang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Voluntary signing of informed consent (2) Over 18 years old (including 18 years old), both male and female (3) ECOG score: 0 ~ 4 points (4) Pathological diagnosis confirmed tumor (5) Full abdominal CT plain scan, CT enhancement and peripheral blood biochemical tests supported the diagnosis of irAEs (6) Patients who require immunotherapy according to the judgment of the treating physician (7) Subject compliance is good
Exclusion criteria
Exclusion criteria: (1) Patients who are using investigational immunotherapy drugs (2) Patients with adverse reactions caused by chemotherapy, targeted therapy and radiation therapy before immunotherapy (3) The researchers judged that it was not suitable to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory specific cytokines and population characteristics of immune cells; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging; | — |
Countries
China
Contacts
Public ContactDong Hangming
Nanfang Hospital of Southern Medical University
Outcome results
None listed